Off-label use of intravitreal triamcinolone acetonide for diabetic macular edema in a pregnant patient
Ahad Fazelat, Kameran LashkariSchepens Eye Research Institute, Harvard Medical School, Boston, MA, USAAbstract: We present a case of diabetic macular edema in a pregnant patient treated with a single intravitreal injection of triamcinolone acetonomide. Initial presentation and serial examinations af...
Guardado en:
Autores principales: | Fazelat A, Lashkari K |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2011
|
Materias: | |
Acceso en línea: | https://doaj.org/article/9da011186cc943b79d5e7da1b9de087a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Intravitreal bevacizumab alone or combined with triamcinolone acetonide as the primary treatment for diabetic macular edema
por: Marey HM, et al.
Publicado: (2011) -
Macular sensitivity and morphology after intravitreal injection of triamcinolone acetonide for macular edema secondary to central retinal vein occlusion
por: Mimura T, et al.
Publicado: (2012) -
Intravitreal triamcinolone for intraocular inflammation and associated macular edema
por: Steven M Couch, et al.
Publicado: (2008) -
Factors associated with visual recovery after sub-Tenon injection of triamcinolone acetonide in diabetic macular edema
por: Kawashima H, et al.
Publicado: (2012) -
The effect of posterior sub-Tenon’s capsule triamcinolone acetonide injection to that of pars plana vitrectomy for diabetic macular edema
por: Nonomura S, et al.
Publicado: (2014)